Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Rare Earth/Strategic Metals (REMX) vs Tempus AI (TEM) Price & Performance

VanEck Rare Earth/Strategic MetalsTrade

Price performance (Past 24H)

Key statistics

VanEck Rare Earth/Strategic Metals vs Tempus AI — how do they compare? VanEck Rare Earth/Strategic Metals trades at $71.1, while Tempus AI trades at $46.96 (market cap $8.80B). The key difference: VanEck Rare Earth/Strategic Metals is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

REMXTEM
Sector
Sector/ThematicBroad Market / Factor
52-Week High
$109.53$103.25
52-Week Low
$49.22$42.37
Market Cap
$8.80B
Enterprise Value
$9.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Rare Earth/Strategic Metals

REMX, the VanEck Rare Earth and Strategic Metals ETF, trades at $69.85, down 3.88% amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average signals against zero bullish, though oscillators show some buying opportunity with RSI readings in oversold territory. Recent news highlights ongoing geopolitical tensions around rare earth supply chains, with China's export controls and US efforts to secure critical minerals driving volatility in the sector.

The ETF offers exposure to 38 global rare earth companies but carries high volatility (~50% annualized) and significant China concentration risk. While strategic metals demand remains strong for technology and defense applications, REMX is best suited as a satellite holding for aggressive portfolios due to its specialized nature and geopolitical sensitivities.

Tempus AI

Tempus AI (TEM) trades at $48.41, down 7.74% amid market reaction to its $1.5 billion acquisition of Personalis. The stock shows bearish technical signals with negative moving averages and oversold RSI levels. Fundamentally, the company maintains strong revenue growth ($1.27B in 2025) but faces significant losses (-$245M net income) and negative margins. Recent news highlights strategic expansion in cancer diagnostics through AI-driven platforms.

Despite analyst optimism (61.5% buy ratings, $68.50 target), TEM faces execution risks from the major acquisition and persistent profitability challenges. The stock's current discount to target offers potential upside if integration succeeds, but high cash burn and competitive pressures require careful monitoring for investors considering entry at these levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Rare Earth/Strategic Metals

REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.

Read more on REMX

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM